Application Nr Approved Date Route Status External Links
ANDA077002 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Digoxin Tablets Are A Cardiac Glycoside Indicated For: Treatment Of Mild To Moderate Heart Failure In Adults. ( 1.1 ) Increasing Myocardial Contractility In Pediatric Patients With Heart Failure.( 1.2 ) Control Of Resting Ventricular Rate In Patients With Chronic Atrial Fibrillation In Adults. ( 1.3 ) 1.1 Heart Failure In Adults Digoxin Tablets Are Indicated For The Treatment Of Mild To Moderate Heart Failure In Adults. Digoxin Tablets Increase Left Ventricular Ejection Fraction And Improve Heart Failure Symptoms As Evidenced By Improved Exercise Capacity And Decreased Heart Failure-Related Hospitalizations And Emergency Care, While Having No Effect On Mortal-Ity. Where Possible, Digoxin Tablets Should Be Used In Combination With A Diuretic And An Angiotensin-Converting Enzyme (ace) Inhibitor. 1.2 Heart Failure In Pediatric Patients Digoxin Tablets Increase Myocardial Contractility In Pediatric Patients With Heart Failure. 1.3 Atrial Fibrillation In Adults Digoxin Tablets Are Indicated For The Control Of Ventricular Response Rate In Adult Patients With Chronic Atrial Fibrillation.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Digoxin

Comments